Farther Finance Advisors LLC Has $68,000 Position in Henry Schein, Inc. (NASDAQ:HSIC)

Farther Finance Advisors LLC increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 58.9% in the 3rd quarter, Holdings Channel.com reports. The firm owned 933 shares of the company’s stock after acquiring an additional 346 shares during the quarter. Farther Finance Advisors LLC’s holdings in Henry Schein were worth $68,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in HSIC. Cromwell Holdings LLC lifted its holdings in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the last quarter. Summit Securities Group LLC bought a new position in Henry Schein during the second quarter worth $31,000. Beach Investment Counsel Inc. PA acquired a new position in Henry Schein during the 2nd quarter valued at $37,000. Blue Trust Inc. raised its stake in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after purchasing an additional 1,100 shares during the period. Institutional investors own 96.62% of the company’s stock.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 1.14% of the company’s stock.

Henry Schein Trading Down 1.2 %

Shares of HSIC stock opened at $67.46 on Wednesday. The company has a market capitalization of $8.41 billion, a P/E ratio of 27.76, a P/E/G ratio of 1.95 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The company has a quick ratio of 0.90, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a 50-day moving average price of $70.40 and a 200 day moving average price of $69.63.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the business earned $1.32 EPS. Henry Schein’s revenue was up .4% compared to the same quarter last year. Research analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on HSIC. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Robert W. Baird decreased their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. Finally, UBS Group dropped their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein currently has a consensus rating of “Hold” and a consensus target price of $77.50.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.